Title: Biotechnology patenting takes off in developing countries

Authors: Uyen Quach, Halla Thorsteinsdottir, James Renihan, Archana Bhatt, Zoe Costa Von Aesch, Peter A. Singer, Abdallah S. Daar

Addresses: Canadian Program on Genomics and Global Health, Joint Centre for Bioethics, University of Toronto, 88 College Street, Toronto, Ontario M5G 1L4, Canada. ' Canadian Program on Genomics and Global Health, Joint Centre for Bioethics, University of Toronto, 88 College Street, Toronto, Ontario M5G 1L4, Canada. ' Canadian Program on Genomics and Global Health, Joint Centre for Bioethics, University of Toronto, 88 College Street, Toronto, Ontario M5G 1L4, Canada. ' Canadian Program on Genomics and Global Health, Joint Centre for Bioethics, University of Toronto, 88 College Street, Toronto, Ontario M5G 1L4, Canada. ' Canadian Program on Genomics and Global Health, Joint Centre for Bioethics, University of Toronto, 88 College Street, Toronto, Ontario M5G 1L4, Canada. ' Canadian Program on Genomics and Global Health, Joint Centre for Bioethics, University of Toronto, 88 College Street, Toronto, Ontario M5G 1L4, Canada. ' Canadian Program on Genomics and Global Health, Joint Centre for Bioethics, University of Toronto, 88 College Street, Toronto, Ontario M5G 1L4, Canada

Abstract: We investigated the levels and patterns of biotechnology patenting in several developing countries by examining patents registered in the US Patent and Trademark Office (USPTO) database. The results showed, firstly, that developing countries have increased their biotechnology patenting during the period with the leading countries demonstrating inventive strengths in this field. Secondly, whereas in some countries national patenting ownership was high in others it was relatively low, which may limit the ability of the countries to harness their inventions. Thirdly, the research sector has been particularly active in patenting, especially in countries with relatively strong track records in developing biotechnology products, but industrial patenting is still limited in most of the countries studied. Finally, several of the countries we examined have a strong focus on health biotechnology compared to other types of biotechnology in their patenting rates. It remains to be seen if the increased patenting will foster biotechnology innovation.

Keywords: intellectual property; patents; biotechnology; developing countries; Brazil; China; Cuba; Egypt; India; South Africa; South Korea; innovation; technological change; South–South; TRIPS; health biotechnology.

DOI: 10.1504/IJBT.2006.008963

International Journal of Biotechnology, 2006 Vol.8 No.1/2, pp.43 - 59

Published online: 09 Feb 2006 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article